Full name
POLIMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
33.1 - Repair of fabricated metal products, machinery and equipment
33.2 - Installation of industrial machinery and equipment and outfit
46.18.Z - Agents specialised in the sale of other particular products
58.1 - Publishing of books, periodicals and other publishing activities
70.22.Z - Business and other management consultancy activities
71.20.A - Food quality testing and analysis
72.1 - Research and experimental development on natural sciences and engineering
77.3 - Rental and leasing of other machinery, equipment and tangible goods
85.5 - Other education
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,4 | 0,2 | 0,8 | 421 |
EBITDA | 0,2 | 0,8 | 292 | |
Short time liabilities | 2,6 | 1,9 | -26,8 | |
Income tax | 0 | -∞ | ||
Equity capital | 0,8 | 1 | 1,7 | 70,8 |
Operating profit (EBIT) | 0,2 | 0,8 | 292 | |
Assets | 3,2 | 3,6 | 3,7 | 1,1 |
Net profit (loss) | 0,3 | 0,1 | 0,7 | 420,8 |
Cash | 0,2 | 0,4 | 150,2 | |
Net income from sale | 5 | 8,1 | 62,7 | |
Liabilities and provisions for liabilities | 2,4 | 2,6 | 1,9 | -26,2 |
Working assets | 3,2 | 3,6 | 3,7 | 1,1 |
Depreciation | 0 | 0 | 0 | |
Basic operational activity income | 3,9 | -∞ | ||
% | % | % | p.p. | |
Profitability of capital | 39,7 | 13,6 | 41,5 | 27,9 |
Equity capital to total assets | 26,2 | 28,2 | 47,6 | 19,4 |
Gross profit margin | 9,5 | 3,1 | 10 | 6,9 |
EBITDA Margin | 3,9 | 9,5 | 5,6 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 191 | 86 | -105 | |
Current financial liquidity indicator | 1.3924529552459717 | 1.908504605293274 | 0,5 | |
Net dept to EBITDA | -0.8769270181655884 | -0.5597882866859436 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane